Suchergebnisse - Marc Raab

Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial von Hans Salwender, Niels Weinhold, Axel Benner, Kaya Miah, Maximilian Merz, Mathias Haenel, Christian Jehn, Elias Mai, Ekaterina Menis, Igor Blau, Christof Scheid, Dirk Hose, Anja Seckinger, Steffen Luntz, Britta Besemer, Markus Munder, Peter Brossart, Bertram Glass, Hans-Walter Lindemann, Katja Weisel, Christine Hanoun, Paul Schnitzler, Sarah Klemm, Hartmut Goldschmidt, Marc Raab, Ahmet Elmaagacli

Volltext

Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysis von Nico Gagelmann, Hermann Einsele, Sarah Flossdorf, Samih Smaili, Klaus Metzeler, Christoph Scheid, Lars Bullinger, Sandra Sauer, Marc Raab, Justus Duyster, Hans Christian Reinhardt, Raphael Teipel, Winfried Alsdorf, Claudia Lengerke, Wolfgang Herr, Natalie Schub, Francis Ayuketang Ayuk, Florian Bassermann, Christian Schultze-Florey, Roland Schroers, Mathias Hänel, Nicola Giesen, Ahmet Elmaagacli, Andreas Burchert, Thomas Weber, Dimitrios Mougiakakos, Stefan Knop, Fabian Müller, Nicolaus Kröger, Maximilian Merz, the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy, DRST

Volltext